Skip to main content
. 2019 Sep 6;68(11):2143–2154. doi: 10.2337/db19-0271

Table 2.

Impact of diabetes and NSI-189 on terminal systemic parameters in mice

N Body weight Blood glucose Blood HbA1c Blood HbA1c Deaths during study
(g) (mg/dL) (%) (mmol/mol)
Type 1: Prevention
 Control + vehicle 10 32.4 ± 4.7* 153 ± 26*** 3.1 ± 0.2*** 10.1 ± 2.7*** 0
 STZ + vehicle 9 28.4 ± 3.0 562 ± 17 6.1 ± 0.2 43.6 ± 2.3 1
 STZ + insulin 8 29.2 ± 2.2 215 ± 132*** 4.0 ± 0.8*** 19.9 ± 8.4*** 2
 STZ + NSI-189 9 29.9 ± 2.2 567 ± 43 6.3 ± 0.7 45.9 ± 7.1 1
Type 1: Intervention
 Control + vehicle 10 31.6 ± 2.2*** 118 ± 12*** ND ND 0
 STZ + vehicle 10 25.9 ± 2.1 559 ± 47 ND ND 0
 STZ + NSI-189 9 27.5 ± 1.7 589 ± 16 ND ND 1
Type 2: Prevention
 WT + vehicle 10 29.6 ± 1.7*** 143 ± 24** 4.1 ± 0.2*** 21.3 ± 1.9*** 0
 WT + NSI-189 10 29.6 ± 1.5*** 161 ± 20** 4.2 ± 0.2*** 21.6 ± 1.8*** 0
db/db + vehicle 10 62.6 ± 7.2 307 ± 180 5.7 ± 1.4 38.9 ± 15.7 0
db/db + NSI-189 8 66.2 ± 2.9 189 ± 19* 5.1 ± 0.9 31.8 ± 10.0 2
Type 2: Intervention
 WT + vehicle 10 30.2 ± 1.2*** 167 ± 9*** ND ND 0
db/db + vehicle 10 54.8 ± 8.0 439 ± 61 ND ND 0
db/db + NSI-189 10 55.6 ± 5.3 483 ± 71 ND ND 0

Data are mean ± SD. Statistical comparison by one-way ANOVA with the Dunnett post hoc test. ND, not determined.

*P < 0.05, **P < 0.01, ***P < 0.001 vs. vehicle-treated diabetic mice.